Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cresco Labs (CRLBF)
OTHER OTC:CRLBF
Cresco Labs (CRLBF) Stock Price & Analysis
2,117 Followers
CRLBF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.00 - $2.77
Previous Close$1.74
Volume262.11K
Average Volume (3M)783.43K
Market Cap
$773.11M
Enterprise Value$1.26B
Total Cash (Recent Filing)$123.16M
Total Debt (Recent Filing)$693.02M
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Aug 14, 2024EPS Estimate
$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding437,685,014
10 Day Avg. Volume503,291
30 Day Avg. Volume783,430
Standard Deviation0.22
R-Squared0.21
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-9.20
Price to Sales (P/S)0.66
Price to Cash Flow (P/CF)4.70
P/FCF Ratio6.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.66
Enterprise Value/Gross Profit3.48
Enterprise Value/Ebitda90.50
Forecast
1Y Price Target
$5.24Price Target Upside196.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Cresco Labs News
PremiumCompany Announcements
Cresco Labs Elects New Board, Enhances Incentive Plan
PremiumCompany Announcements
Cresco Labs Triumphs with Strong Q1 Financials
PremiumCompany Announcements
Cresco Labs Announces Q1 2024 Earnings Date
Bulls Say, Bears Say
Bulls Say
Cost ManagementThe Company reduced SG&A costs by 4.9% even while maintaining the #1 position in core markets such as IL, PA, and MA, and as transactions grew by 4%.
Financial PerformanceThe successful execution of this strategy is evident after stringing together three consecutive quarters of strong adjusted EBITDA beats, generating higher than anticipated revenue, and displaying a remarkable improvement in FCF generation.
Growth DriversCresco has a compelling pipeline of growth drivers including the launch of adult-use sales in Ohio, potential for Florida and Pennsylvania to convert to an adult-use market, and the ramp up of New York’s adult-use program.
Bears Say
Capital ExpenditureManagement introduced a capex guidance for 2024 of $50-70M, which currently stands above estimates at $45.1M and implies a meaningful step up in the subsequent quarters from the $3.8M deployed, likely implying lower FCF generation for the remainder of the year.
Revenue OutlookA modest decline in revenue is expected in '24.
Sales GrowthManagement maintained its relatively conservative 2024 outlook, reiterating its guidance of flattish sales in Q224 and Q324.
---
Options Prices
Currently, No data available
---
Ownership Overview
57.53% Insiders
1.65% Mutual Funds
0.52% Other Institutional Investors
40.30% Public Companies and
Individual Investors
CRLBF FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was $1.00 and its highest was $2.77 in the past 12 months.
What is Cresco Labs’s market cap?
Currently, no data Available
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is Aug 14, 2024 which is in 27 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on May 15, 2024. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.02 by $0.01.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is $0.02.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 328,586,640 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.02. Following the earnings report the stock price went up 3.465%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in CRLBF
---
Cresco Labs Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.24 (196.88% Upside)
$5.24 (196.88% Upside)
Blogger Sentiment
Bullish
CRLBF Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $554.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.4%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.79%
12-Months-Change
Fundamentals
Return on Equity
-27.50%
Trailing 12-Months
Asset Growth
-12.29%
Trailing 12-Months
Company Description
Cresco Labs
Cresco Labs Inc is a Canada based company engaged in the production and sale of cannabis. The company distribute its products to dispensaries nationwide, including several dispensaries owned and operated by its team. Its product includes Reserve, Remedi, Mindy's. All the revenues of the company were generated in the United States. It has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, and Arizona.
---
CRLBF Company Deck
---
CRLBF Earnings Call
Q1 2024
0:00 / 0:00
---
CRLBF Stock 12 Month Forecast
Average Price Target
$5.24
▲(196.88% Upside)
Best Analysts Covering CRLBF
1 Year
1 Year Success Rate
9/24 ratings generated profit
1 Year Average Return
+10.34%
reiterated a buy rating 2 months ago
Copying Derek Dley's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +10.34% per trade.
---